Latest prostatectomy Stories

First Study Ever to Analyze 25 years of Data after Radiation Therapy for Prostate Cancer Patients ATLANTA, Feb. 26, 2013 /PRNewswire/ -- The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate. This study, 25 Year Disease Free Survival Rate after Irradiation of Prostate Cancer Calculated with the Prostate...

Between 2007 and 2010, the use of robotically-assisted hysterectomy for benign gynecologic disorders increased substantially, although, when compared with laparoscopic hysterectomy, the robotic procedure appears to offer little short-term benefit and is accompanied by significantly greater costs, according to a study appearing in the February 20 issue of JAMA. "Hysterectomy for benign gynecologic disease is one of the most commonly performed procedures for women. Overall, 1 in 9 women in...

NEW YORK, Feb. 15, 2013 /PRNewswire/ -- Staying ahead of the curve often comes with a price. In the case of prostate cancer, treatment innovations fuel ongoing debate over the cost-benefit analysis of new technologies and modalities. In an institution-based study led by Dr. David Samadi, Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York, Robotic-Assisted Laparoscopic Prostatectomy (RALP) was found...

SAN DIEGO, Feb. 14, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced new data supporting the clinical validation and utility of Decipher(TM), a transformative genomic test that forecasts risk of metastasis in men with prostate cancer. An analysis of men at risk of recurrence after prostate cancer surgery showed Decipher was a better predictor of metastasis than conventional risk assessment tools such as PSA, tumor stage and grade. A separate study found that the more...

SAN DIEGO, Feb. 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that four posters highlighting the performance and clinical utility of its Decipher(TM) test will be presented at the 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). Decipher is a transformative genomic decision tool that provides accurate and actionable information to forecast patients that are at risk for lethal prostate cancer. Abstracts will be made available to...

NEW YORK, Feb. 5, 2013 /PRNewswire/ -- A new Prostate Cancer Outcomes Study (PCOS) in the January 31, 2013 New England Journal of Medicine, http://www.nejm.org/doi/full/10.1056/NEJMoa1209978 reported the functional status of men after robotic prostate surgery and external-beam radiation therapy (EBRT) for localized prostate cancer. Most men in the study (now ages 70-89) reported some problems with urinary control and sex after treatment for prostate cancer. Long-term side effects,...

NEW YORK, Jan. 22, 2013 /PRNewswire/ -- Not all robots are created equal, particularly when it comes to prostate cancer, says world-renowned prostate cancer surgeon, Dr. David Samadi. Specializing in minimally invasive da Vinci robotic prostatectomy surgery, Dr. Samadi is not only Vice Chairman, Department of Urology at The Mount Sinai Medical Center; he is also Chief of Robotics and Minimally Invasive Surgery. (Photo: http://photos.prnewswire.com/prnh/20130122/NY45644 ) Robots...

NEW YORK, Jan. 11, 2013 /PRNewswire/ -- A comparative review of more than 230 previously published studies bumps radical prostate removal surgery above radiation in cost-effectiveness, quality of life after treatment, and patient survival. Surgery, whether performed traditionally, laparoscopically, or robotically, demonstrated improved outcomes across all three factors when compared to radiation for prostate cancer in the form of intensity-modulate radiation therapy, brachytherapy,...

NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Prostate cancer diagnoses may bring out the fight in men but patients need to know which punch to throw first. When diagnosed early, prostate cancer is highly treatable and patients most often choose between robotic prostate removal surgery or radiation for prostate cancer, including external beam radiation therapy (EBRT) and brachytherapy seed radiation. (Logo: http://photos.prnewswire.com/prnh/20130108/NY39190LOGO ) Three concerns drive...

NEW YORK, Dec. 3, 2012 /PRNewswire/ -- The majority of patients undergoing RALP (robot-assisted laparoscopic prostatectomy) surgery for localized prostate cancer do not regret their treatment decision, according to findings published in The Journal of Urology, December 2012, http://www.jurology.com/article/S0022-5347(12)04453-9/abstract. Analysis indicates the primary factors contributing to postoperative quality of life, and therefore satisfaction or dissatisfaction with treatment...